Literature DB >> 26795948

[Drug-resistant tuberculosis. Epidemiology, diagnostics and therapy].

M P Grobusch1,2, F Schaumburg3, E Altpeter4, S Bélard5,6.   

Abstract

Drug-resistant tuberculosis (DR-TB) is one of the serious problems in the fight against tuberculosis on a global scale. This review article describes in brief the global epidemiology, diagnostics and treatment of DR-TB. The situation in Germany, Switzerland and Austria is addressed in detail. The article concludes with a presentation of current research topics in the field of resistant TB.

Entities:  

Keywords:  Austria; Germany; Mycobacterium tuberculosis; Resistent tuberculosis; Switzerland

Mesh：

Substances：

Year:  2016        PMID： 26795948     DOI： 10.1007/s00108-015-0010-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  34 in total

Review 1.  Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis.

Authors:  Rajhmun Madansein; Shreemanta Parida; Nesri Padayatchi; Nalini Singh; Iqbal Master; Kantharuben Naidu; Alimuddin Zumla; Markus Maeurer
Journal:  Int J Infect Dis       Date:  2015-03       Impact factor: 3.623

Review 2.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

3.  Cost of multi drug resistance tuberculosis in Germany.

Authors:  R Diel; A Nienhaus; N Lampenius; S Rüsch-Gerdes; E Richter
Journal:  Respir Med       Date:  2014-10-15       Impact factor: 3.415

Review 4.  Bedaquiline for the treatment of drug-resistant tuberculosis.

Authors:  Sabine Bélard; Charlotte C Heuvelings; Saskia Janssen; Martin P Grobusch
Journal:  Expert Rev Anti Infect Ther       Date:  2015-03-22       Impact factor: 5.091

5.  Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.

Authors:  Heather J Zar; David Hanslo; Patricia Apolles; George Swingler; Gregory Hussey
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

Review 6.  Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.

Authors:  Alimuddin Zumla; Jeremiah Chakaya; Rosella Centis; Lia D'Ambrosio; Peter Mwaba; Matthew Bates; Nathan Kapata; Thomas Nyirenda; Duncan Chanda; Sayoki Mfinanga; Michael Hoelscher; Markus Maeurer; Giovanni Battista Migliori
Journal:  Lancet Respir Med       Date:  2015-03-09       Impact factor: 30.700

7.  Towards host-directed therapies for tuberculosis.

Authors:  Alimuddin Zumla; Markus Maeurer; Jeremiah Chakaya; Michael Hoelscher; Francine Ntoumi; Roxana Rustomjee; Cristina Vilaplana; Dorothy Yeboah-Manu; Voahangy Rasolof; Paula Munderi; Nalini Singh; Eleni Aklillu; Nesri Padayatchi; Eusebio Macete; Nathan Kapata; Modest Mulenga; Gibson Kibiki; Sayoki Mfinanga; Thomas Nyirenda; Leonard Maboko; Alberto Garcia-Basteiro; Niaina Rakotosamimanana; Matthew Bates; Peter Mwaba; Klaus Reither; Sebastien Gagneux; Sarah Edwards; Elirehema Mfinanga; Salim Abdulla; Pere-Joan Cardona; James B W Russell; Vanya Gant; Mahdad Noursadeghi; Paul Elkington; Maryline Bonnet; Clara Menendez; Tandakha N Dieye; Bassirou Diarra; Almoustapha Maiga; Abraham Aseffa; Shreemanta Parida; Christian Wejse; Eskild Petersen; Pontiano Kaleebu; Matt Oliver; Gill Craig; Tumena Corrah; Leopold Tientcheu; Martin Antonio; Martin Rao; Timothy D McHugh; Aziz Sheikh; Giuseppe Ippolito; Gita Ramjee; Stefan H E Kaufmann; Gavin Churchyard; Andrie Steyn; Martin Grobusch; Ian Sanne; Neil Martinson; Rajhmun Madansein; Robert J Wilkinson; Bongani Mayosi; Marco Schito; Robert S Wallis
Journal:  Nat Rev Drug Discov       Date:  2015-07-17       Impact factor: 84.694

8.  Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study.

Authors:  Deliwe Nkosi; Saskia Janssen; Xavier Padanilam; Rianna Louw; Colin N Menezes; Martin P Grobusch
Journal:  BMC Health Serv Res       Date:  2013-07-09       Impact factor: 2.655

9.  Assessing the consequences of stigma for tuberculosis patients in urban Zambia.

Authors:  Anne Lia Cremers; Myrthe Manon de Laat; Nathan Kapata; Rene Gerrets; Kerstin Klipstein-Grobusch; Martin Peter Grobusch
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.

Authors:  E Marais; C K Mlambo; J J Lewis; N Rastogi; T Zozio; M P Grobusch; A Duse; T Victor; R W Warren
Journal:  Infection       Date:  2013-12-21       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.